Opinion

Koehn v. Secretary of Health & Human Services

  • 773 F.3d 1239
  • 2014 U.S. App. LEXIS 22780
  • 2014 WL 6804880
Court
Court of Appeals for the Federal Circuit
Filed
Dec 4, 2014
Status
Published
On the bench
Moore, O'Malley, Reyna
Cited by
441 cases
Authority
More cited than 33.6%

noting that certain blood testing experiment could only provide useful data based on in vitro efforts

How later courts described this case

  • noting that certain blood testing experiment could only provide useful data based on in vitro efforts
  • ruling that the special master was not arbitrary and capricious in finding that the onset of a condition months after vaccination was not consistent with a theory based on cytokines
  • holding that special master was not arbitrary in finding an onset of injury seven months after vaccination was incompatible with a theory based upon cytokines
  • holding that special master was not arbitrary in finding an onset of injury seven months after vaccination incompatible with a theory based upon cytokines

Written by the judges who cited it.

The opinion

United States Court of Appeals

for the Federal Circuit

______________________

CHERYL KOEHN, as Mother and Next Friend of,

VANESSIA KOEHN,

Petitioners-Appellants,

v.

SECRETARY OF HEALTH AND HUMAN

SERVICES,

Respondent-Appellee.

______________________

2014-5054

______________________

Appeal from the United States Court of Federal

Claims in No. 1:11-vv-00355-EGB, Senior Judge Eric G.

Bruggink.

______________________

Decided: December 4, 2014

______________________

P. LEIGH O’DELL, Beasley, Allen, Crow, Methvin,

Prortis, & Miles, P.C., of Montgomery, Alabama, argued

for petitioners-appellants.

DARRYL R. WISHARD, Trial Attorney, Torts Branch,

Civil Division, United States Department of Justice, of

Washington, DC, argued for respondent-appellee. With

him on the brief were STUART F. DELERY, Assistant Attor-

ney General, RUPA BHATTACHARYYA, Director, VINCENT J.

2 KOEHN v. HHS

MATANOSKI, Deputy Director, and GABRIELLE M.

FIELDING, Assistant Director.

______________________

Before MOORE, O’MALLEY, and REYNA, Circuit Judges.

Opinion for the court filed by Circuit Judge O’MALLEY.

Concurring opinion for the court filed by Circuit Judge

MOORE.

O’MALLEY, Circuit Judge.

Cheryl Koehn appeals from a U.S. Court of Federal

Claims judgment upholding a Special Master’s denial of

compensation for Koehn’s daughter’s systemic juvenile

idiopathic arthritis (“SJIA”) allegedly caused by a vaccine.

Although the Special Master’s assessment of Koehn’s

medical theory of causation contains several flaws, the

Special Master had a sufficient basis upon which to

determine that Koehn did not meet her burden of demon-

strating a proximate temporal relationship between her

daughter receiving the vaccine and developing SJIA. We

therefore affirm.

BACKGROUND

Children with SJIA, an autoinflammatory disease,

exhibit symptoms including arthritis, a fever, and a rash,

and may experience flares involving similar symptoms as

well as muscle and joint pain. Many of these symptoms

result from dysfunctional production of proteins called

cytokines, which certain cells release almost immediately

after the body comes into contact with an antigen. Cyto-

kines signal other cells to generate an immune response.

Pro-inflammatory cytokines, like those associated with

SJIA, can lead to fever or other inflammation. Examples

of SJIA medication include prednisone, which reduces

inflammation and suppresses the immune system, and

etanercept, which inhibits a cytokine linked to SJIA.

KOEHN v. HHS 3

Gardasil is a vaccine that immunizes against four

strands of human papillomavirus (“HPV”). The vaccine,

administered in three doses, contains virus-like particles

created from an HPV protein, as well as an adjuvant,

which assists in generating a robust immune response to

promote long-term immunity.

I.

Koehn’s daughter, Vanessia, was born in February

1995, and was generally healthy for the first twelve years

of her life. Dr. Elena Regala administered Vanessia’s first

dose of Gardasil in February 2008 and her second dose in

April 2008. On June 21, 2008, Vanessia experienced a

rash all over her body. Dr. Regala, believing it to be an

allergic reaction, prescribed Benadryl and prednisone

three days later. Vanessia’s rash disappeared within

three days. On June 28, 2008, Vanessia went to Marian

Medical Center for severe joint pain and high fever.

Vanessia had stopped taking prednisone by that time,

which coincided with her developing pain in her knees,

thighs, and calves. Vanessia saw a rheumatologist at the

hospital and received another prescription for prednisone.

The hospital discharged her on July 2, 2008 with a pre-

sumptive diagnosis of juvenile idiopathic arthritis. Va-

nessia’s only symptom at discharge was a rash.

On July 8, 2008, Vanessia saw Dr. Deborah McCurdy,

a pediatric rheumatologist, who noted that Vanessia’s

family history included juvenile idiopathic arthritis and

concluded that SJIA was a likely diagnosis. Dr. McCurdy

communicated these findings to Dr. Regala, who adminis-

tered Vanessia’s third dose of Gardasil on August 19,

2008. Vanessia was no longer taking prednisone at that

time, but had started taking etanercept. Vanessia experi-

enced a flare of SJIA with fever, rash, and joint pain on

August 25, 2008. In September 2008, Dr. McCurdy

concluded that, though Vanessia had improved, she still

showed signs of SJIA. Dr. McCurdy noted that Vanessia

4 KOEHN v. HHS

complained of SJIA symptoms after she stopped taking

prednisone, and that she had swollen ankles and knees.

II.

On behalf of Vanessia, Koehn filed an off-Table injury

claim under the Vaccine Act. For off-Table injuries, which

are those that do not appear on the statutory Vaccine

Injury Table, 42 C.F.R. § 100.3 (2014), the petitioner must

prove causation-in-fact. Andreu v. Sec’y of Health &

Human Servs., 569 F.3d 1367, 1374 (Fed. Cir. 2009). A

petitioner must prove the following by a preponderance of

the evidence to establish causation: (1) a medical theory

causally connecting the vaccination to the injury; (2) a

logical sequence of cause and effect demonstrating that

the vaccination caused the injury; and (3) a proximate

temporal relationship between the vaccine and the injury.

Althen v. Sec’y of Health & Human Servs. 418 F.3d 1274,

1278 (Fed. Cir. 2005).

Koehn presented the opinion of Dr. Michael McCabe,

who has a Ph.D. in microbiology and immunology and has

researched environmental factors that affect immune

response, to support her claim. Dr. McCabe asserted that

Vanessia had a predisposition for SJIA, and that Gardasil

was an environmental trigger because the vaccine caused

a strong response in the same cytokines which are

dysregulated in SJIA. He relied on several articles to

support his theory, including an article discussing a study

that tested cytokine levels in women who received an

HPV vaccine on a three-dose regimen similar to Gardasil

(“Pinto article”). In the study referred to by the Pinto

article, researchers gave twenty female participants an

HPV vaccine on the same three dose regimen as Gardasil,

and drew blood before the first injection and one month

after each of the second and third injections. The re-

searchers either stimulated the blood samples with vary-

ing amounts of a virus-like particle in the vaccine or

provided no stimulation at all. Cytokine levels were

KOEHN v. HHS 5

relatively consistent in the vaccinated blood that received

no stimulation. Cytokine levels increased, however, for

the vaccinated blood that received the virus-like particle,

and the elevated cytokines were the same as those

dysregulated in SJIA. Dr. McCabe asserted that this

commonality supports his theory that Gardasil triggered

Vanessia’s SJIA.

Dr. McCabe further testified that the lack of epidemi-

ological studies on SJIA shows that the disease is too rare

for scientists to be able to generate statistically relevant

epidemiological data. As an example, Dr. McCabe pre-

sented an article discussing a study that evaluated the

medical history of approximately 189,000 women to

determine whether they developed an autoimmune re-

sponse after receiving a quadrivalent HPV vaccine (“Chao

article”). Though the Chao article did not find such a

connection, Dr. McCabe relied on the article to demon-

strate that SJIA is so rare that, despite the large sample

size, it was not large enough to detect an increased rate of

SJIA following HPV vaccination.

Finally, Dr. McCabe suggested that, because patients

who receive Gardasil develop sufficient antibodies for

immunity within seven months, Vanessia’s development

of SJIA within seven months after receiving Gardasil was

evidence of a proximate temporal relationship.

The government’s expert, Dr. Carlos Rose, is a pediat-

ric rheumatologist and routinely treats children with

SJIA, but has not researched the HPV vaccine or the role

of cytokines in SJIA. Dr. Rose asserted that Vanessia’s

SJIA was more likely a coincidence. According to Dr.

Rose, the most relevant results from the Pinto article

were that the vaccinated blood samples with no stimula-

tion had relatively consistent cytokine levels, whereas

SJIA patients experience a pattern of up-regulated cyto-

kine levels. Dr. Rose also cited an article referring to a

study of roughly 60,000 individuals which found no in-

6 KOEHN v. HHS

creased risk for autoimmune disorders for participants

who received vaccines, including an HPV vaccine called

Cervarix that uses a different adjuvant than Gardasil

(“Verstraeten article”).

III.

The Special Master denied Koehn compensation. The

Special Master held that Koehn did not meet her burden

under the first Althen prong, finding that Dr. McCabe’s

medical theory was unprecedented and had not been peer-

reviewed or published. In addition, the Special Master

found that the relevant scientific community, pediatric

rheumatologists, did not accept Dr. McCabe’s theory,

primarily basing that conclusion on Dr. Rose’s testimony

that he, as head of pediatric rheumatology at his hospital,

did not recall ever hearing of such a theory. The Special

Master acknowledged that the Verstraeten article in-

volved a different HPV vaccine than Gardasil and that its

sample size was likely insufficient to produce statistically

significant results. But, because Chao involved Gardasil

and had more than double the sample size of the Ver-

straeten article, the Special Master held that the articles

“[t]aken together” weighed against Dr. McCabe’s theory.

J.A. 143. Finally, the Special Master focused on the Pinto

article’s results indicating that cytokine levels increased

only when the researchers stimulated the blood, and Dr.

Rose’s statement that “[o]f course when you stimulate

with an antigen you get more cytokines released.”

Moving to the second Althen prong, the Special Mas-

ter held that Koehn did not establish a logical sequence of

cause and effect between Gardasil and Vanessia’s SJIA.

In reaching this conclusion, the Special Master found Dr.

Rose’s opinion more persuasive because he is a doctor that

treats patients, whereas Dr. McCabe does not treat pa-

tients.

The Special Master further held that Koehn did not

meet her burden under the third Althen prong because

KOEHN v. HHS 7

the record did not support Dr. McCabe’s assertion that

development of SJIA within a seven-month interval was

sufficient to establish a proximate temporal relationship.

Dr. McCabe reasoned that the onset of SJIA aligns with

the time period during which Gardasil patients develop a

sufficient immune response, which is seven months. The

Special Master found, however, that both Dr. McCabe and

Dr. Rose agreed that the immune system releases cyto-

kines soon after the body encounters an antigen, which is

inconsistent with Dr. McCabe’s theory that onset of the

disease could take many months. Dr. McCabe attempted

to explain this contradiction by asserting that there is an

“amplification process,” but the Special Master concluded

that he did not sufficiently support this explanation.

The Court of Federal Claims upheld the Special Mas-

ter’s decision. Koehn timely appealed. We have jurisdic-

tion under 42 U.S.C. § 300aa–12(f) (2012).

DISCUSSION

In Vaccine Act cases, we apply the same standard of

review that the Court of Federal Claims applied to the

Special Master’s decision. Moberly v. Sec’y of Health &

Human Servs., 592 F.3d 1315, 1321 (Fed. Cir. 2010).

Although we review legal determinations without defer-

ence, we review the Special Master’s findings of fact

under the arbitrary and capricious standard. Griglock v.

Sec’y of Health & Human Servs., 687 F.3d 1371, 1374

(Fed. Cir. 2012).

Though the Special Master had sufficient grounds to

deny Koehn’s petition because Koehn failed to meet her

burden under the third Althen prong, we begin by recog-

nizing that the Special Master committed several errors

in the assessment of the first and second Althen prongs.

As to the first Althen prong, for instance, the Special

Master based his conclusion that the relevant scientific

community did not accept Dr. McCabe’s theory on Dr.

Rose’s statement that he did not recall ever hearing of

8 KOEHN v. HHS

such a theory. 1 To impute Dr. Rose’s anecdotal statement

to the scientific community was wholly unreasonable.

Another example is the Special Master’s finding that,

under the second Althen prong, Dr. Rose’s opinion was

more persuasive than Dr. McCabe’s opinion because Dr.

Rose treats patients and Dr. McCabe does not. We see no

reasonable basis for why this distinction has any mean-

ingful effect on the cause and effect inquiry in this case,

and the Special Master provided none. While we recog-

nize that it is within the Special Master’s discretion to

weigh the relevant evidence, the Special Master cannot

manipulate the analysis in a manner calculated to arrive

at a conclusion that he or she has already reached.

1 Had the Special Master properly evaluated the ev-

idence, we believe the Special Master would have likely

found that Koehn met her burden under the first Althen

prong. The Pinto article demonstrated that the partici-

pants who received the HPV vaccine had increased levels

of the same cytokines dysregulated in SJIA. Dr. Rose

asserted that the article showed increased levels only

when the vaccinated blood received a stimulus. Koehn

explains, however, that measurement of cytokine levels

can only occur in blood samples outside the body, and the

only way to “replicate what is going on in the body” is to

introduce an antigen to the blood sample assay. Oral Arg.

at 5:24–6:56, available at http://oralarguments.cafc.

uscourts.gov/default.aspx?fl=2014-5054.mp3. A stimulus

was therefore necessary to measure cytokine levels.

Especially given the low incidence rate of SJIA, requiring

a measurement without a stimulus would have compelled

Koehn to present more than what is scientifically possible

or legally necessary. Thus, Koehn likely presented a

viable, “legally probable” medical theory that “there would

only be an upregulation in cytokines [that are associated

with SJIA] if those cells are told to do so [by the HPV

vaccine.]” Id. at 6:50–6:56; Moberly, 592 F.3d at 1322.

KOEHN v. HHS 9

Because Koehn failed to meet her burden under the

third Althen prong, however, and failure to do so under

any one of the Althen prongs is dispositive of this case, the

Special Master correctly denied Koehn’s petition.

We agree with the Special Master that Koehn’s evi-

dence failed to establish a proximate temporal relation-

ship between Vanessia’s Gardasil vaccine and

development of SJIA under Althen’s third prong. This

prong “requires preponderant proof that the onset of

symptoms occurred within a timeframe for which, given

the medical understanding of the disorder’s etiology, it is

medically acceptable to infer causation-in-fact.” de Bazan

v. Sec’y of Health & Human Servs., 539 F.3d 1347, 1352

(Fed. Cir. 2008).

The record did not support Dr. McCabe’s suggestion

that the appropriate timeframe for first exhibiting symp-

toms of SJIA caused by Gardasil can extend up to seven

months. Dr. McCabe asserted that onset of SJIA can

occur within seven months of receiving Gardasil because

it normally takes patients seven months after receiving

Gardasil to develop a sufficient immune response. Dr.

McCabe did not, however, explain why the timing of SJIA

onset aligns with the timing of a sufficient immune re-

sponse in patients receiving the vaccine. Even Dr. McCa-

be agreed that the immune system produces cytokines

quickly after the body encounters an antigen, which is

inconsistent with his theory that onset of the disease

could take many months. Dr. McCabe’s position that the

amount of time for developing sufficient antibodies for

immunity after receiving a vaccine is always consistent

with injury from the vaccine is a proposition that, without

any evidentiary support, we simply cannot accept.

Koehn argues that Dr. McCabe explained this contra-

diction by referring to an “amplification process.” But

Dr. McCabe only speculated that there was a delay in the

onset of SJIA because certain regulatory cells and in-

10 KOEHN v. HHS

flammatory mediators in the body that are also purport-

edly active in response to an antigen may counteract the

effects of cytokines, and admitted that “none of this was

measured in” Vanessia. J.A. 232. We find the Special

Master’s conclusion that Dr. McCabe’s explanation lacked

sufficient support neither arbitrary nor capricious.

Thus, while we find fault with aspects of the Special

Master’s Althen analysis, we ultimately affirm his deci-

sion to deny compensation to Koehn. We agree that

Koehn did not sufficiently establish why onset of SJIA can

occur within seven months after receiving the first dose of

Gardasil, especially when cytokine release is generally a

more immediate response.

AFFIRMED

COSTS

No costs.

United States Court of Appeals

for the Federal Circuit

______________________

CHERYL KOEHN, as Mother and Next Friend of,

VANESSIA KOEHN,

Petitioners-Appellants,

v.

SECRETARY OF HEALTH AND HUMAN

SERVICES,

Respondent-Appellee.

______________________

2014-5054

______________________

Appeal from the United States Court of Federal

Claims in No. 1:11-vv-00355-EGB, Senior Judge Eric G.

Bruggink.

______________________

MOORE, Circuit Judge, concurring.

I join fully in the majority’s analysis of the third

Althen prong. I recognize the strength of the reasons

cited by the majority for being troubled by the Special

Master’s analysis on the first and second Althen prongs. I

do not believe, however, that they present adequate

grounds for reversal given the highly deferential standard

of review we must apply.

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.